Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. (2022)
Attributed to:
Randomised trials in cardiovascular and metabolic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehab863
PubMed Identifier: 34910136
Publication URI: http://europepmc.org/abstract/MED/34910136
Type: Journal Article/Review
Volume: 43
Parent Publication: European heart journal
Issue: 14
ISSN: 0195-668X